Status:
COMPLETED
Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens
Lead Sponsor:
Maggiore Bellaria Hospital, Bologna
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of the study is to determine if rapid on-site evaluation of EBUS-TBNA samples can increase the percentage of patients with advanced non-squamous non-small cell lung cancer in whom both pat...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Suspected hilar or mediastinal lymph node metastasis from lung cancer
Exclusion
- Pregnancy
- Uncontrolled coagulopathy
- Refusal to sign informed consent
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT01799382
Start Date
February 1 2013
End Date
October 1 2014
Last Update
October 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maggiore Hospital
Bologna, Emilia-Romagna, Italy, 40133